Chengguan District, Lanzhou, Gansu, China sales01@liwei-chem.com 1557459043@qq.com
Follow us:



Sucrose Stearate BP EP USP Pharma Grade: Commentary and Insights

Historical Development

Sucrose stearate has seen a journey shaped by the intersection of biochemistry, consumer safety, and pharmaceutical demand. Originally derived during a period when sugar chemistry played a central role in early food and drug formulations, sucrose esters like sucrose stearate quickly gained traction in pharmaceutical circles. Researchers spent years figuring out how to harness natural biochemical compounds that combined safety with reliable function. By the late 20th century, as pharmaceutical companies started prioritizing non-toxic excipients, sucrose stearate made its way into official pharmacopoeias such as BP, EP, and USP. These regulatory frameworks forced manufacturers to lift their standards, demanding greater purity, traceability, and evidence of safety.

Product Overview

Manufacturers produce sucrose stearate through a reaction that binds sucrose with fatty acid stearic acid, creating an emulsifier and stabilizing agent tailored for pharmaceutical applications. Its pharmaceutical-grade status stems from high purity, verified by batch testing and stringent quality certifications. Sucrose stearate plays well with both water and oils, making it useful not just as a simple additive but as a problem-solver in tough formulation environments. Medications containing lipophilic active ingredients benefit from its ability to ease blending and create smoother tablet coatings that don't crumble.

Physical & Chemical Properties

Sucrose stearate typically appears as a white, odorless, and slightly sweet powder. With a melting point ranging between 50°C and 65°C, it offers good thermal stability for most pharmaceutical processes. Its amphiphilic structure, with both hydrophilic and lipophilic sections, gives this compound its versatility. Sucrose stearate dissolves in alcohols and warm water, allowing technicians to adjust concentration and processing temperature without headaches. Its molecular structure resists hydrolysis at neutral pH, drawing sharp lines between itself and other, more fickle emulsifiers.

Technical Specifications & Labeling

Pharmaceutical-grade sucrose stearate must meet strict standards. Lot-to-lot consistency matters to drug companies and regulators alike, so manufacturers conduct analyses for acid value, saponification value, water content, and microbial contamination. The European Pharmacopoeia and similar compendia require accurate labeling that includes lot number, expiration date, and storage requirements. Labels often mention particle size distribution, guaranteeing smooth integration into various dosage forms. Without clear labeling and verification of purity, regulatory pushback can delay entire product lines.

Preparation Method

The making of sucrose stearate involves a transesterification reaction. Technicians heat sucrose and vegetable-based stearic acid in the presence of alkaline catalysts. They carefully control temperature and agitation, as excessive heat burns sugar, while poor agitation leads to uneven mixing. After the main reaction, manufacturers purify the product by repeated washing and vacuum drying, getting rid of unreacted ingredients and contaminants. Filtration steps catch unwanted particulates, ensuring every batch meets the demands of pharmaceutical consistency.

Chemical Reactions & Modifications

Chemists often tweak the sucrose-to-stearate ratio, tailoring the final product for different pharmaceutical purposes. This ratio adjustment can sharpen or soften emulsifying power, depending on the formulation challenge. Further maturation can involve blending with other sucrose esters or surfactants, allowing for fine-tuned control over hydrophilic-lipophilic balance. In some cases, researchers look for ways to modify the chain length or degree of esterification to improve compatibility with specific active pharmaceutical ingredients. Each tweak brings trade-offs, so decision-makers depend on lab trials and historical data.

Synonyms & Product Names

Industry circles refer to this compound using several alternative names, including sucrose octadecanoate and sugar stearic acid ester. Catalogs and pharmaceutical databases connect these synonyms to a host of product codes depending on manufacturer and region. Many ingredient suppliers standardize their product identity by referencing the chemical abstract service (CAS) number and pharmacopoeial grade. Across Japan, Europe, and North America, companies use brand-specific names that all trace back to the same core ingredient.

Safety & Operational Standards

Safety remains the bedrock of any ingredient destined for medicine. Regulatory agencies considered various toxicology and allergenicity studies before endorsing sucrose stearate for pharmaceutical use. GMP-certified facilities handle production, storage, and shipping, minimizing contamination risks. Manufacturers invest in robust training programs for plant workers, with batch testing keeping microbial contamination and allergens in check. Companies also conduct stability studies under accelerated conditions, measuring for any degradation products that could affect health.

Application Area

Sucrose stearate finds broad application in making oral solid dosage forms, including tablets and capsules, as its emulsifying properties decrease granule friability and improve mouthfeel. It features heavily in pediatric and geriatric medicine, because its sensory neutrality minimizes patient rejection. Liquid suspensions benefit from its ability to keep oil droplets dispersed, stopping floating oil slicks and stubborn clumps. Even topical drug formulations draw on its gentle emulsification, pairing with both water-based and ointment bases without irritating the skin. Hospital compounding pharmacists trust it for its safety record and multi-functional use, especially where sensitive populations require extra vigilance.

Research & Development

Labs keep pushing the boundaries, with current research examining better combinations of sucrose stearate with novel delivery systems like nanoparticles and microemulsions. Investigators measure how slight chemical modifications might boost drug bioavailability for poorly soluble molecules. Some studies pit sucrose stearate against older emulsifiers, seeing fewer allergic responses and lower off-tastes. Research groups look for more sustainable process methods, hoping to use less energy and greener feedstocks, especially as regulatory and consumer pressure mounts for climate-friendly production.

Toxicity Research

Toxicologists ran animal and human studies to confirm the non-carcinogenic, non-mutagenic nature of sucrose stearate. Dosing above typical pharmaceutical levels rarely triggers acute toxicity or chronic organ damage in lab settings. Clinical studies confirm the absence of serious allergic reactions or cytotoxic effects, even after continuous administration in multi-dose products. Researchers keep monitoring new data, particularly in vulnerable patients, but the track record so far shows a strong margin of safety. Regulatory agencies rely on this research, updating monographs only if future evidence indicates new risks.

Future Prospects

The outlook for sucrose stearate in pharma points to steady growth, thanks to its proven safety and reliable functionality. Analysts predict higher use in injectable formulations and biologic drug stabilizers as new delivery routes require non-irritating excipients. Demand from developing markets keeps increasing, as their pharmaceutical manufacturers adopt stricter international quality standards. Researchers continue to explore new modifications to the molecule that could expand its use into personalized medicine and advanced drug delivery systems. As patient preferences shift toward safer, cleaner-label drugs, sucrose stearate remains well-positioned as a cornerstone excipient shaped by decades of careful study.




What is Sucrose Stearate BP EP USP Pharma Grade used for?

Smoothing Out the Edges in Pharmaceuticals

Walk down the aisle at any pharmacy and pick up a packet of tablets. Beyond the active drug that doctors prescribe, you’ve got a mix of ingredients making the pill stable, easy to swallow, and effective over time. One of these helpers is sucrose stearate in pharma grade, known in chemistry labs as BP, EP, or USP, depending on which pharmacopoeia standard you follow.

What Sucrose Stearate Brings to the Table

In my own time working in a pharmacy, I noticed how often patients complained about chalky textures or tablets that fall apart. Sucrose stearate steps in as an emulsifier and a stabilizer. It helps keep injectable solutions clear, prevents separation in creams, and gives tablets a smoother polish. In simple terms, this ingredient controls how oil and water sit together, especially in delicate liquid medicines and creams where consistency is everything.

People often overlook safe, food-like additives in medicine. Sucrose stearate comes from sugar and stearic acid, both common in food and cosmetics. Scientists depend on it because it’s non-toxic, safe to consume, and unlikely to irritate skin or organs. The pharma grade label points to careful checks: no unexpected residues, no microbes lurking in the powder, and tight quality rules the pharmaceutical world demands.

Why This Matters for Patients

Let’s say your grandmother takes a heart pill every morning. If moisture hits that pill, or if the ingredients don’t mix evenly, she could face unexpected side effects. Sucrose stearate helps seal out moisture and keeps pills from falling apart in the bottle. It binds everything together, so each pill carries the right dose with the same texture as the last one. This kind of reliability builds trust between patients, pharmacists, and the companies making the drugs.

Challenges That Come Up

Even the best additives bring their own headaches. Sucrose stearate only works if mixed correctly with other raw ingredients, or tablets might get too sticky or brittle. More than once, I’ve seen rushed batches split during shipping, leaving patients with half-doses or powdery residue at the bottom of the package. Manufacturers tackle this by investing in better mixing equipment and performing tough stability checks on each batch.

The sourcing side matters too. Any global shortage in raw materials—maybe from supply chain wrinkles or crop failures—pushes up costs and leaves gaps in production. Pharmaceutical companies need to build stronger supplier relationships and keep alternative sources ready, so patients aren’t left waiting.

Room for Smarter Choices

There’s been a push for cleaner ingredient lists in medicines, just as we’ve seen with foods. Some companies explore alternatives to stearates and long ingredient lists. Sucrose stearate holds its place because it’s been studied, trusted by regulators, and used worldwide, but patients and doctors stand to gain as research brings new options.

If companies keep testing and streamlining production, and regulatory agencies stay alert, medicines can stay both safe and accessible. Sucrose stearate keeps working behind the scenes, making everyday treatments simpler and more dependable for everyone.

What are the specifications and purity standards for Sucrose Stearate BP EP USP Pharma Grade?

Understanding Sucrose Stearate in Medicine

Anyone who’s wandered behind the scenes of a pharmaceutical lab will know there are no shortcuts on ingredient quality. Sucrose stearate, a compound formed from combining sugar and stearic acid, takes a special place in drug manufacturing. It shows up as a reliable, safe excipient, helping tablets keep their shape and allowing drugs to dissolve as expected. Strict standards set by BP (British Pharmacopoeia), EP (European Pharmacopoeia), and USP (United States Pharmacopeia) mark the difference between medical-grade and regular-use additives. These benchmarks demand attention to both content and purity.

What Counts in Specifications?

Sucrose stearate doesn’t just get tossed into the mix. Labs put every batch through rigorous testing. The specs go beyond just physical appearance — though even this gets scrutiny. It’s usually a white or off-white, odorless, fine powder. Its index for acid value and saponification must fall within set limits: you’ll often see acid value below 6, and saponification value in the range of 145 to 170. Moisture plays a key role as well; too much water in the mix and you’re looking at product breakdown or issues with stability. Most pharma grades keep water content below 4%.

You’ll also see purity standards that leave little room for error. Residual solvents, toxic heavy metals (like lead, arsenic, mercury), and impurities cannot creep past trace levels. Sodium, potassium, and calcium have to stay below specific limits since drug reactions can become unpredictable with too many ions floating around. Trans fatty acids and unsaponifiable matter must fit within what’s been set by BP, EP, or USP. Each authority draws the line with its own chapter in their respective pharmacopoeia, but the goal remains the same: high purity, safe for human use.

Microbial Safety and Beyond

Bacteria and mold have no place in pharma-grade compounds. Manufacturers run microbial limit tests to prove the batch stays below defined thresholds. Total aerobic count, yeast and molds, and the absence of pathogens such as E. coli and Salmonella come standard. In my time consulting for a medium-sized generics maker, the strictness on cleaning and testing stuck with me. No amount of after-the-fact lab work can save a batch if contamination sneaks in early.

Reliable Sourcing and Traceability

Authorities want full traceability for every ingredient used. Auditors will check batch numbers, supplier data, and origins of both sucrose and stearic acid. Without a chain of paperwork, certification gets pulled or delayed. The biggest challenge in my experience? Consistency. One manufacturer’s “pharma grade” could look different from another’s unless every step stays documented and aligned with the primary pharmacopoeia. A pharma firm pays for this kind of reliability; patients expect tablets to perform without surprises.

Looking at the Solutions

Better analytics help labs measure purity with greater accuracy. High-performance liquid chromatography and gas chromatography now pick apart tiny trace contaminants. Automation, in both production and lab testing, cuts down on human error. Beyond tech, open communication between suppliers and manufacturers gives early warning about supply chain hiccups or new regulatory demands. In my own dealings, I saw biggest gains when teams treated specifications as a shared responsibility, not a formality for paperwork. Trust grows when the numbers match the paperwork and the end product performs as promised.

Is Sucrose Stearate BP EP USP Pharma Grade safe for pharmaceutical applications?

Understanding Sucrose Stearate’s Role in Medication

Sucrose stearate appears in many pharmacy labs as an emulsifier and stabilizer. Picture a tablet or suspension—often, this ingredient makes sure the active compounds stay put, blend nicely, and taste manageable. As a mixture of sucrose (sugar) and stearic acid (a fatty acid found in many foods), the compound looks fairly simple at a molecular level, yet its role can make or break a drug’s performance.

Why Safety Questions Keep Popping Up

Most people will recognize sucrose and stearic acid from their everyday lives: Sucrose enters the kitchen in sugar bowls, stearic acid fills up plenty of butters and chocolates. That familiarity doesn’t always translate into safety in a medical context, so regulators have stepped in. Sucrose stearate’s BP, EP, and USP grades mean the compound must hit purity and safety benchmarks recognized in British, European, and United States pharmacopeias. These standards come about from years of research, testing, and field feedback.

In practical terms, pharmaceutical-grade sucrose stearate undergoes heavy scrutiny before being allowed in a pill or syrup. Lab professionals look for impurities and possible pesticides. They analyze how the ingredient breaks down in the body, keeping an eye out for toxic byproducts. Results repeatedly point to a compound the digestive tract handles much like common foods, breaking it down to basic sugars and harmless fatty acids. No strange or unexpected molecules appear in the bloodstream after consumption, based on published human and animal studies.

Allergies and Sensitivities: Who Should Pay Attention?

Though rare, some people might want to dig deeper. Take those with sensitivities to certain fats or sugars: Manufacturers extract stearic acid from vegetable or animal sources, so knowing the supply chain matters. Most reputable suppliers avoid animal derivatives, reducing the risk for allergies tied to those sources. Label transparency helps someone who deals with allergies or intolerances, especially if they use several medications daily. Not every manufacturer handles raw materials the same, and final pill recipes vary. Pharmacists and healthcare providers often suggest asking about inactive ingredients during medication reviews.

Oversight and the Importance of Continuous Testing

Released science and regulatory catchups give peace of mind. The FDA, EMA, and other watchdogs periodically review pharmaceutical excipients, including sucrose stearate. If any batch carries risks, recalls and investigations ramp up, drawing on adverse reaction reports and updated research. Unannounced inspections and modern analytical tools catch problems early in the supply chain.

Improvements and Keeping Patients Informed

Few topics matter more to patients than what goes inside medication. Growing public interest has pushed some pharmaceutical companies to publish excipient sources and safety records. Physicians and pharmacists now offer smartphone apps and printed guides listing inactive ingredient profiles. These changes put more power in the hands of patients, encouraging candid conversations before new drugs enter daily life.

Addressing Remaining Challenges

Genuine improvement lies in improving ingredient transparency, not just aiming for minimum regulatory thresholds. Companies can adopt rapid testing for every batch, rather than spot-checks. Traceability, right down to farms or chemical plants, backs up pharma labeling claims. Patient feedback tools—online surveys or hotlines—help spot new kinds of intolerances or interaction risks early. All these approaches aim to build trust and safety, closing the loop between manufacturers, regulators, healthcare professionals, and medicine users.

What are the typical packaging and shelf life details for Sucrose Stearate BP EP USP Pharma Grade?

The Package Matters More Than You Think

Every pharmaceutical pro knows how a little slip-up with packaging can send a top-notch excipient right into the trash. Sucrose stearate, often used as an emulsifier or stabilizer in pharmaceutical products, is no different. I remember walking into a depot and spotting a busted fiber drum—white powder leaking out, labels stained, and inventory guys scrambling. That batch was rejected on the spot. This experience drove home the idea that getting packaging right saves both money and headaches.

Keep It Dry, Keep It Tight

Manufacturers usually rely on HDPE drums for sucrose stearate shipments. These drums—sometimes lined with food-grade liner bags—lock out humidity and oxygen, which can ruin a shipment if left unchecked. Occasionally, you’ll see fiberboard drums with sealed inner linings. For smaller operations or sample-size requests, double-sealed aluminum bags end up as the go-to. This packaging prevents clumping, keeps out moisture, and stops cross-contamination.

Some companies use air-tight plastic pails with tamper-evident lids, sized from 5 kg up to 25 kg. A few bigger players offer palletized bulk bags, but you won’t find those in pharma unless working with high-volume contract manufacturing. The main goal: block out moisture. Sucrose stearate, being part sugar, soaks up water from the air. Excess humidity leads to caking or even microbial growth. Once, a batch stored in a poorly sealed bag went from free-flowing powder to rock-solid clumps in three weeks during a muggy monsoon season. That’s lost revenue and trust.

Shelf Life: Use It or Lose It

In my years sourcing excipients, shelf life marked a recurring question from regulatory teams. For sucrose stearate, manufacturers often quote a shelf life of 24 months if kept in original, unopened packaging and stored under clean, dry conditions away from heat sources and direct sunlight. The product starts out as a consistent white powder. With time, even in the best packaging, it can absorb odors or yellow if exposed to light or air.

A product that sits too long in sub-par storage risks failing later quality checks. I’ve seen inspectors catch a batch where powder stuck to the container walls, a clear sign of moisture uptake and likely hydrolysis. Companies that care about keeping things safe don’t accept that risk.

Storage and Quality Go Hand in Hand

Most pharma-grade sucrose stearate gets stored at room temperature—somewhere between 15°C and 25°C—inside clean rooms or temperature-controlled warehouses. Facilities equipped with dehumidifiers and strict pest control keep nature from ruining a batch. On my end, I’ve pushed for environmental monitoring as part of standard procedure, and believe me, this kind of discipline pays off with fewer out-of-spec test results.

Packaging comes with batch numbers and production dates, making stock rotation straightforward. I worked with a team that always checked oldest stock first, and the difference in stability tests told its own story. Products that cycled out faster kept quality high, customer complaints low.

Looking Forward: Keeping It Safe and Simple

Sucrose stearate demands strong packaging and careful storage to meet pharmaceutical needs. Focusing on HDPE drums or double-lined bags with tight seals can protect the investment. Companies that review inventory practices, install climate controls, and never ignore the details end up with the most reliable product. Attention to these basics stops a steady stream of minor disasters from snowballing into something big.

How should Sucrose Stearate BP EP USP Pharma Grade be stored and handled?

Understanding the Real Risks

Sucrose stearate shows up in all sorts of pharmaceutical and food applications. In my lab days, I handled different pharma-grade excipients, and one lesson sticks out: treating these substances casually only leads to mistakes down the line. With sucrose stearate, clumping and contamination can sneak up surprisingly fast if you skip basic protocols.

Storage Practices Worth Following

A cool, dry storeroom matters more than any fancy container. Humidity may seem harmless, but one summer I saw entire stocks of excipients ruined because a window was left open. Sucrose stearate absorbs moisture, so even a few hours of exposure leave it sticky and useless. Standard practice in well-run facilities includes monitored temperature and humidity, clear labeling, and sealed packaging.

Room temperature is usually ideal—extremes quickly reduce shelf life. Direct sunlight isn’t just about heat; light breaks down many pharmaceutical ingredients. Keep the chemical away from windows and high-traffic aisles. Shelves should be clean and reserved specifically for excipients, not shared with cleaning products or open materials. I’ve seen cross-contamination happen in chaotic storerooms where folks thought “it won’t matter.” Contamination costs time and money, but it also undermines product safety.

Handling Precautions from the Ground Up

Before opening a bag, wash hands and put on a fresh lab coat and gloves. It sounds basic but cutting these steps puts the whole batch at risk. I once watched a colleague skip gloves, thinking “just this once.” That small lapse contaminated more than a kilo—gone to waste. Scoops, spatulas, and containers should all be dry and clean. Even a single grain of sugar or a drop of liquid can start undesirable reactions in the material.

Measuring doesn’t have to get complicated, but don’t eyeball quantities. Use calibrated weighing equipment and always document what you’re taking and when. This way, if something’s off with a batch later, tracking down the error is possible. Think of it less as paperwork and more as a tool for future problem-solving.

Minimizing Exposure and Loss

Every time the package opens, a chance for contamination sneaks in. Only remove what’s actually needed, and seal the bag tightly right after. Modern pharma packaging often comes with built-in zip locks or tamper-evident seals, but in some settings, resealable liners work fine as long as you press out extra air. Label every open package with the date and lot number—skip this and you risk using outdated or mixed-up ingredients.

Short-term contact with the open air might not result in visible changes, but quality always starts at the ground level. Clear, dry work surfaces, routine cleaning schedules, and well-trained staff keep products safe from the start. Training new staff on the “why” rather than just the “how” made a big difference in my experience. Once people understood what could go wrong, careful handling became a habit rather than a chore.

Moving Toward Safer, Smarter Practice

Mistakes are easiest to prevent through culture, not just checklists. Top-tier pharmaceutical and food operations achieve low error rates by fostering ownership and good habits. In my time, regular audits and open conversations about near-misses kept everyone sharp. As the industry looks to reduce waste and maintain safety, attention to detail in how we store and handle sucrose stearate won’t go out of style.

Sucrose Stearate BP EP USP Pharma Grade
Names
Preferred IUPAC name O-β-D-glucopyranosyl-(1→2)-α-D-fructofuranosyl octadecanoate
Other names Sucrose octadecanoate
Sucrose stearic acid ester
Stearic acid sucrose ester
Sucrose stearate
Stearic acid, ester with sucrose
Pronunciation /ˈsuːkrəʊs ˈstiəreɪt ˌbiːˈpiː ˌiːˈpiː ˌjuːˈɛsˈpiː ˈfɑːrmə ɡreɪd/
Identifiers
CAS Number 37318-31-3
Beilstein Reference 1788358
ChEBI CHEBI:53692
ChEMBL CHEMBL1230419
ChemSpider 2312186
DrugBank DB09450
ECHA InfoCard ECHA InfoCard: 100.249.098
EC Number EC 245-260-1
Gmelin Reference Gmelin Reference: "83274
KEGG C16236
MeSH D013429
PubChem CID 24883129
RTECS number WKJ70044D9
UNII Z9R3996KFS
UN number UN number: Not regulated
Properties
Chemical formula C30H54O12
Molar mass 681.02 g/mol
Appearance White or almost white powder
Odor Odorless
Density DENSITY : 1.03 g/cm3
Solubility in water Insoluble in water
log P -7.2
Vapor pressure Negligible
Acidity (pKa) ~12.6
Basicity (pKb) 11.8
Magnetic susceptibility (χ) Diamagnetic (-9.9 × 10⁻⁶ cgs)
Refractive index (nD) 1.45 – 1.47
Viscosity Viscosity: "40-90 cP (2% solution)
Dipole moment 1.90 D
Thermochemistry
Std enthalpy of formation (ΔfH⦵298) -2065 kJ/mol
Std enthalpy of combustion (ΔcH⦵298) –17635 kJ/mol
Pharmacology
ATC code A24AC02
Hazards
Main hazards May cause mild skin and eye irritation.
GHS labelling GHS labelling: Not classified as hazardous according to GHS.
Pictograms GHS07, GHS08
Hazard statements Non-hazardous according to GHS classification.
Precautionary statements Precautionary statements: P261, P264, P270, P272, P273, P280, P301+P312, P302+P352, P305+P351+P338, P332+P313, P337+P313, P362+P364, P501
NFPA 704 (fire diamond) NFPA 704: 1-1-0
Autoignition temperature > 420 °C
Lethal dose or concentration LD50 (Rat, oral) > 10,000 mg/kg
LD50 (median dose) LD50 (median dose): >10,000 mg/kg (oral, rat)
NIOSH WSH3672000
PEL (Permissible) Not established
Related compounds
Related compounds Sucrose distearate
Sucrose palmitate
Sucrose laurate
Sucrose monostearate
Sucrose esters of fatty acids